Gene therapy of brain cancer by drug delivery nanocapsules
An all-in-one polymeric nanocapsule system that combines blood-brain barrier (BBB) crossing and glioblastoma (GBM) dual-targeting peptide, intratumoral degradable disulfide cross-linker, and genome editing tool CRISPR-Cas9 is reported to show exquisite BBB penetration and brain tumor therapy with ne...
Saved in:
Published in | Matter Vol. 5; no. 8; pp. 2502 - 2504 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
Elsevier Inc
03.08.2022
|
Online Access | Get full text |
ISSN | 2590-2385 2590-2385 |
DOI | 10.1016/j.matt.2022.06.038 |
Cover
Loading…
Abstract | An all-in-one polymeric nanocapsule system that combines blood-brain barrier (BBB) crossing and glioblastoma (GBM) dual-targeting peptide, intratumoral degradable disulfide cross-linker, and genome editing tool CRISPR-Cas9 is reported to show exquisite BBB penetration and brain tumor therapy with negligible off-target gene editing.
An all-in-one polymeric nanocapsule system that combines blood-brain barrier (BBB) crossing and glioblastoma (GBM) dual-targeting peptide, intratumoral degradable disulfide cross-linker, and genome editing tool CRISPR-Cas9 is reported to show exquisite BBB penetration and brain tumor therapy with negligible off-target gene editing. |
---|---|
AbstractList | An all-in-one polymeric nanocapsule system that combines blood-brain barrier (BBB) crossing and glioblastoma (GBM) dual-targeting peptide, intratumoral degradable disulfide cross-linker, and genome editing tool CRISPR-Cas9 is reported to show exquisite BBB penetration and brain tumor therapy with negligible off-target gene editing.
An all-in-one polymeric nanocapsule system that combines blood-brain barrier (BBB) crossing and glioblastoma (GBM) dual-targeting peptide, intratumoral degradable disulfide cross-linker, and genome editing tool CRISPR-Cas9 is reported to show exquisite BBB penetration and brain tumor therapy with negligible off-target gene editing. |
Author | Wang, Ran Zhou, Xue-Quan Sun, Wen Bonnet, Sylvestre |
Author_xml | – sequence: 1 givenname: Xue-Quan surname: Zhou fullname: Zhou, Xue-Quan organization: State Key Laboratory of Fine Chemicals, Dalian University of Technology, 2 Linggong Road, Dalian 116024, P.R. China – sequence: 2 givenname: Ran surname: Wang fullname: Wang, Ran organization: State Key Laboratory of Fine Chemicals, Dalian University of Technology, 2 Linggong Road, Dalian 116024, P.R. China – sequence: 3 givenname: Wen surname: Sun fullname: Sun, Wen email: sunwen@dlut.edu.cn organization: State Key Laboratory of Fine Chemicals, Dalian University of Technology, 2 Linggong Road, Dalian 116024, P.R. China – sequence: 4 givenname: Sylvestre surname: Bonnet fullname: Bonnet, Sylvestre email: bonnet@chem.leidenuniv.nl organization: Leiden Institute of Chemistry, Universiteit Leiden, Einsteinweg 55, 2333 CC Leiden, Netherlands |
BookMark | eNp9kM9KAzEQh4MoWGtfwFNeYNdJstk_4kWKVqHgRc8hm8xqyjZbkrSwb--WehAPPc0w_L5h5rshl37wSMgdg5wBK-83-VanlHPgPIcyB1FfkBmXDWRc1PLyT39NFjFuAKYkE1UhZuRhhR5p-sagdyMdOtoG7Tw12hsMtB2pDfsvarF3Bwwj9doPRu_ivsd4S6463Udc_NY5-Xx5_li-Zuv31dvyaZ0ZAZAyYVuNlSzqpmBgUHMJRWulbWtbiq7CrkFemkawuuNFZaWRjcAKudEap7EUc1Kf9powxBiwU8Ylndzg03Rrrxioowa1UUcN6qhBQakmDRPK_6G74LY6jOehxxOE01MHh0FF43DyYV1Ak5Qd3Dn8Bx9xeTU |
CitedBy_id | crossref_primary_10_1016_j_nantod_2024_102310 crossref_primary_10_3390_jcm13237449 crossref_primary_10_1002_adfm_202412040 |
Cites_doi | 10.1016/j.ejpb.2015.03.018 10.1002/smll.202101460 10.1126/science.aba8853 10.1038/s41573-020-0090-8 10.1126/scitranslmed.3003601 10.1126/sciadv.abm8011 |
ContentType | Journal Article |
Copyright | 2022 Elsevier Inc. |
Copyright_xml | – notice: 2022 Elsevier Inc. |
DBID | AAYXX CITATION |
DOI | 10.1016/j.matt.2022.06.038 |
DatabaseName | CrossRef |
DatabaseTitle | CrossRef |
DatabaseTitleList | |
DeliveryMethod | fulltext_linktorsrc |
EISSN | 2590-2385 |
EndPage | 2504 |
ExternalDocumentID | 10_1016_j_matt_2022_06_038 S2590238522003332 |
GroupedDBID | AAEDW AAIAV AALRI AAXUO ADJPV AFTJW ALMA_UNASSIGNED_HOLDINGS AMRAJ EBS EJD FDB HX~ M3Z M41 OK1 0R~ AAMRU AAYWO AAYXX ABDGV ABJNI ACVFH ADCNI ADVLN AEUPX AFPUW AGCQF AIGII AITUG AKAPO AKBMS AKRWK AKYEP APXCP CITATION ROL |
ID | FETCH-LOGICAL-c300t-3dbae75489410cea2504bd5db8d63f7ef9e26c9318f247d5c593e7e2caaec9353 |
ISSN | 2590-2385 |
IngestDate | Tue Jul 01 03:52:37 EDT 2025 Thu Apr 24 23:04:03 EDT 2025 Thu Jul 20 20:09:33 EDT 2023 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 8 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c300t-3dbae75489410cea2504bd5db8d63f7ef9e26c9318f247d5c593e7e2caaec9353 |
PageCount | 3 |
ParticipantIDs | crossref_citationtrail_10_1016_j_matt_2022_06_038 crossref_primary_10_1016_j_matt_2022_06_038 elsevier_sciencedirect_doi_10_1016_j_matt_2022_06_038 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2022-08-03 |
PublicationDateYYYYMMDD | 2022-08-03 |
PublicationDate_xml | – month: 08 year: 2022 text: 2022-08-03 day: 03 |
PublicationDecade | 2020 |
PublicationTitle | Matter |
PublicationYear | 2022 |
Publisher | Elsevier Inc |
Publisher_xml | – name: Elsevier Inc |
References | Mitchell, Billingsley, Haley, Wechsler, Peppas, Langer (bib2) 2021; 20 Walton, Christie, Whittaker, Kleinstiver (bib4) 2020; 368 Yao, Sun, Huang, Dou, Lin, Chen, Ruan, Mao, Yu, Zeng (bib6) 2012; 4 Pérez-Herrero, Fernández-Medarde (bib1) 2015; 93 Zou, Sun, Yang, Zheng, Shimoni, Ruan, Wang, Zhang, Yin, Huang (bib5) 2022; 8 Li, Sun, Li, Luo, He, Sun (bib3) 2021; 17 Yao (10.1016/j.matt.2022.06.038_bib6) 2012; 4 Li (10.1016/j.matt.2022.06.038_bib3) 2021; 17 Walton (10.1016/j.matt.2022.06.038_bib4) 2020; 368 Mitchell (10.1016/j.matt.2022.06.038_bib2) 2021; 20 Zou (10.1016/j.matt.2022.06.038_bib5) 2022; 8 Pérez-Herrero (10.1016/j.matt.2022.06.038_bib1) 2015; 93 |
References_xml | – volume: 17 start-page: 2101460 year: 2021 ident: bib3 article-title: Small-molecule prodrug nanoassemblies: an emerging nanoplatform for anticancer drug delivery publication-title: Small – volume: 8 start-page: eabm8011 year: 2022 ident: bib5 article-title: Blood-brain barrier-penetrating single CRISPR-Cas9 nanocapsules for effective and safe glioblastoma gene therapy publication-title: Sci. Adv. – volume: 93 start-page: 52 year: 2015 end-page: 79 ident: bib1 article-title: Advanced targeted therapies in cancer: drug nanocarriers, the future of chemotherapy publication-title: Eur. J. Pharm. Biopharm. – volume: 368 start-page: 290 year: 2020 end-page: 296 ident: bib4 article-title: Unconstrained genome targeting with near-PAMless engineered CRISPR-Cas9 variants publication-title: Science – volume: 20 start-page: 101 year: 2021 end-page: 124 ident: bib2 article-title: Engineering precision nanoparticles for drug delivery publication-title: Nat. Rev. Drug Discov. – volume: 4 start-page: 130ra48 year: 2012 ident: bib6 article-title: Targeted delivery of PLK1-siRNA by ScFv suppresses Her2 publication-title: Sci. Transl. Med. – volume: 93 start-page: 52 year: 2015 ident: 10.1016/j.matt.2022.06.038_bib1 article-title: Advanced targeted therapies in cancer: drug nanocarriers, the future of chemotherapy publication-title: Eur. J. Pharm. Biopharm. doi: 10.1016/j.ejpb.2015.03.018 – volume: 17 start-page: 2101460 year: 2021 ident: 10.1016/j.matt.2022.06.038_bib3 article-title: Small-molecule prodrug nanoassemblies: an emerging nanoplatform for anticancer drug delivery publication-title: Small doi: 10.1002/smll.202101460 – volume: 368 start-page: 290 year: 2020 ident: 10.1016/j.matt.2022.06.038_bib4 article-title: Unconstrained genome targeting with near-PAMless engineered CRISPR-Cas9 variants publication-title: Science doi: 10.1126/science.aba8853 – volume: 20 start-page: 101 year: 2021 ident: 10.1016/j.matt.2022.06.038_bib2 article-title: Engineering precision nanoparticles for drug delivery publication-title: Nat. Rev. Drug Discov. doi: 10.1038/s41573-020-0090-8 – volume: 4 start-page: 130ra48 year: 2012 ident: 10.1016/j.matt.2022.06.038_bib6 article-title: Targeted delivery of PLK1-siRNA by ScFv suppresses Her2+ breast cancer growth and metastasis publication-title: Sci. Transl. Med. doi: 10.1126/scitranslmed.3003601 – volume: 8 start-page: eabm8011 year: 2022 ident: 10.1016/j.matt.2022.06.038_bib5 article-title: Blood-brain barrier-penetrating single CRISPR-Cas9 nanocapsules for effective and safe glioblastoma gene therapy publication-title: Sci. Adv. doi: 10.1126/sciadv.abm8011 |
SSID | ssj0002213743 |
Score | 2.2124627 |
Snippet | An all-in-one polymeric nanocapsule system that combines blood-brain barrier (BBB) crossing and glioblastoma (GBM) dual-targeting peptide, intratumoral... |
SourceID | crossref elsevier |
SourceType | Enrichment Source Index Database Publisher |
StartPage | 2502 |
Title | Gene therapy of brain cancer by drug delivery nanocapsules |
URI | https://dx.doi.org/10.1016/j.matt.2022.06.038 |
Volume | 5 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEBZpcumltDShadqiQ2-Lgy1ZXju3tLSEhBaaB7vkYixp3BIWb1jsw-bXZ8aSHw2b0PRizGDLluZjNCN9M2LssymzJM4MsfsjGcQafTitNUYpZSxDa-JCAyU4__iZnFzFp3M1H2VcU3ZJrQ_N3ca8kv_RKspQr5Ql-wzN9o2iAO9Rv3hFDeP1n3RMNaMnLoOq3SjXdN4D8bgMrMivtKvm98TCgrgX60lVVDhxYVS88LzB7iCnoh5xdK__LBsa93kDwa9mwM7MLyyfD6KLpjVZsyGb7AvRZlqzfrFeUAEPT631ywoYkRINQg7WB8OiMMD53G05wwaZN59qhJJ0bApVKEbTKpVK22iy3erBzSE66MRtFaKtp-pKvvxdH_vBvNWzCTui2k1ObeTURk5sPZm-YDsCwwc02DvHZ-ezs371TYhIuuyLvk8-o8qR_x7-zGavZeSJXL5mr3wIwY8dHt6wLajesiPCAvdY4MuSt1jgDgtcrzlhgXdY4GMs7LKr798uv54E_lyMwMgwrANpdQFTDDWzOAoNFDS02iqrU5vIcgplBiIxGVrrUsRTq4zKJExBmKIAFCu5x7arZQXvGDcJVWhLs1BbjNOt0GmpMowxQQFtCUf7LOr6nRtfNJ7OLlnkjw_6Ppv079y6kilPPq264cy90-ecuRwB8sR775_1lQP2cgD5B7Zdrxr4iN5krT95aNwDavJzLg |
linkProvider | Library Specific Holdings |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Gene+therapy+of+brain+cancer+by+drug+delivery+nanocapsules&rft.jtitle=Matter&rft.au=Zhou%2C+Xue-Quan&rft.au=Wang%2C+Ran&rft.au=Sun%2C+Wen&rft.au=Bonnet%2C+Sylvestre&rft.date=2022-08-03&rft.issn=2590-2385&rft.eissn=2590-2385&rft.volume=5&rft.issue=8&rft.spage=2502&rft.epage=2504&rft_id=info:doi/10.1016%2Fj.matt.2022.06.038&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_matt_2022_06_038 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2590-2385&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2590-2385&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2590-2385&client=summon |